Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 3/20 | 0.55 |
| ▸ | ACACA | Q13085 | 3/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.54 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.50 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.50 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6341556 | 0.90 | ALOX5 (0.51) | ACACBACACAFFAR1FFAR4OPRM1 | |
| SCHEMBL7452934 | 0.89 | SRD5A2 (0.54) | ACACBFFAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL6341082 | 0.84 | FFAR1 (0.68) | FFAR1FFAR4ALOX5NR4A1NR4A2 | |
| SCHEMBL6349045 | 0.83 | PPARD (0.49) | ACACBACACAFFAR1FFAR4ALOX5 | |
| SCHEMBL6338798 | 0.83 | FFAR4 (0.54) | ACACBACACAFFAR1FFAR4 | |
| SCHEMBL1066614 | 0.82 | FFAR1 (0.70) | FFAR1FFAR4ALOX5NR4A1NR4A2 | |
| SCHEMBL6339254 | 0.82 | NR4A2 (0.68) | ACACBACACAOPRM1OPRD1OPRK1 | |
| SCHEMBL11816285 | 0.82 | EGLN1 (0.49) | OPRM1OPRD1OPRK1P4HTMPTGDR2 | |
| SCHEMBL1547117 | 0.81 | LMNA (0.64) | ACACBACACAOPRM1OPRD1OPRK1 | |
| SCHEMBL4222632 | 0.81 | FFAR1 (0.68) | FFAR1FFAR4ALOX5NR4A1NR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6890932-B2 | Immunoglobulin e antibody suppressors | TEIJIN LIMITED (JP) | 2005-05-10 | — | — | US | disclosed |
| EP-1101755-B1 | ANTHRANILIC ACID DERIVATIVES | TEIJIN LTD (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-20030232811-A1 | Immunoglobulin e antibody suppressors | TEIJIN LIMITED | 2003-12-18 | — | — | US | disclosed |
| US-6649656-B1 | Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents | TEIJIN LIMITED (JP) | 2003-11-18 | — | — | US | disclosed |
| EP-1101755-A1 | ANTHRANILIC ACID DERIVATIVES | TEIJIN LIMITED (JP) | 2001-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232811-A1 | Immunoglobulin e antibody suppressors | IGLV6-57, FCGRT, IGSF11 | ACACB 1367/4885ACACA 1115/4885FFAR1 1564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.